🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis

RecruitingPhase 3Ages 19 Years - 65 YearsAllAlexandria University
NCT05756179 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with mild to moderate disease activity. * Patient age must be more than 18 years. Exclusion Criteria: * Pregnant and lactating females. * Patients with liver, renal impairment or any other inflammatory diseases. * Patients on TNF-α (tumor necrosis factor- α) or IL-1β (interleukin-1β) antagonists.
💊

What it tests

  • Diosmin and Hesperidin Combination
📍

Where

1 site
Alexandria university hospital
Alexandria, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy